Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial

BACKGROUND Nasal continuous positive airway pressure (NCPAP) is widely used as a treatment for obstructive sleep apnoea. However, to date there are no randomised controlled trials of this therapy against a well-matched control. We undertook a randomised prospective parallel trial of therapeutic NCPAP for obstructive sleep apnoea compared with a control group on subtherapeutic NCPAP. METHODS Men with obstructive sleep apnoea, defined as an Epworth sleepiness score of 10 or more and ten or more dips per h of more than 4% SaO2 caused by obstructive sleep apnoea on overnight sleep study, were randomly assigned therapeutic NCPAP or subtherapeutic NCPAP (about 1 cm H2O) for 1 month. Primary outcomes were subjective sleepiness (Epworth sleepiness score), objective sleepiness (maintenance of wakefulness test), and SF-36 questionnaire measurements of self-reported functioning and well-being. FINDINGS 107 men entered the study: 53 received subtherapeutic NCPAP and 54 therapeutic NCPAP. Use of NCPAP by the two treatment groups was similar: 5.4 h (therapeutic) and 4.6 h (subtherapeutic) per night. Subtherapeutic NCPAP did not alter the overnight number of SaO2 dips per h compared with baseline, and thus acted as a control. Therapeutic NCPAP was superior to subtherapeutic NCPAP in all primary outcome measures. The Epworth score was decreased from a median of 15.5 to 7.0 on therapeutic NCPAP, and from 15.0 to 13.0 on subtherapeutic NCPAP (between treatments, p<0.0001). Mean maintenance-of-wakefulness time increased from 22.5 to 32.9 min on therapeutic NCPAP and, not significantly, from 20.0 to 23.5 min on subtherapeutic NCPAP (between treatments p<0.005). Effect sizes for SF-36 measures of energy and vitality were 1.68 (therapeutic) and 0.97 (subtherapeutic) NCPAP (between treatments p<0.0001). For mental summary score, the corresponding values were 1.02 and 0.4 (between treatments p=0.002). INTERPRETATION Therapeutic NCPAP reduces excessive daytime sleepiness and improves self-reported health status compared with a subtherapeutic control. Compared with controls, the effects of therapeutic NCPAP are large and confirm previous uncontrolled clinical observations and the results of controlled trials that used an oral placebo.

[1]  M. Johns.  Daytime sleepiness, snoring, and obstructive sleep apnea. The Epworth Sleepiness Scale. , 1993, Chest.

[2]  J R Stradling,et al.  Variation in the arousal pattern after obstructive events in obstructive sleep apnea. , 1999, American journal of respiratory and critical care medicine.

[3]  J. Stradling,et al.  Automatic nasal continuous positive airway pressure titration in the laboratory: patient outcomes. , 1997, Thorax.

[4]  J. Stradling,et al.  Use of the Epworth Sleepiness Scale to demonstrate response to treatment with nasal continuous positive airways pressure in patients with obstructive sleep apnoea. , 1995, Respiratory medicine.

[5]  J. Krieger,et al.  DANGEROUS HYPOXAEMIA DURING CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT OF OBSTRUCTIVE SLEEP APNOEA , 1983, The Lancet.

[6]  J. Stradling,et al.  Randomised prospective parallel trial of therapeutic versus subtherapeutic nasal continuous positive airway pressure on simulated steering performance in patients with obstructive sleep apnoea , 2000, Thorax.

[7]  M M Mitler,et al.  A normative study of the maintenance of wakefulness test (MWT). , 1997, Electroencephalography and clinical neurophysiology.

[8]  N. Douglas,et al.  Long-term use of CPAP therapy for sleep apnea/hypopnea syndrome. , 1999, American journal of respiratory and critical care medicine.

[9]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[10]  J. Stradling,et al.  Comparison of three measures of quality of life outcome in the evaluation of continuous positive airways pressure therapy for sleep apnoea , 1997, Journal of sleep research.

[11]  S. Greenfield,et al.  The Medical Outcomes Study. An application of methods for monitoring the results of medical care. , 1989, JAMA.

[12]  J. Walsworth-Bell.  Sleep apnoea and the misuse of evidence-based medicine , 1997, The Lancet.

[13]  P. Lavie,et al.  A crossover study comparing the efficacy of continuous positive airway pressure with anterior mandibular positioning devices on patients with obstructive sleep apnea. , 1996, Chest.

[14]  P. Robin.  GLOSSOPTOSIS DUE TO ATRESIA AND HYPOTROPHY OF THE MANDIBLE , 1934 .

[15]  M. Crossley,et al.  Positional treatment vs continuous positive airway pressure in patients with positional obstructive sleep apnea syndrome. , 1999, Chest.

[16]  N J Douglas,et al.  Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome. , 1992, Archives of internal medicine.

[17]  I. Deary,et al.  Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome , 1994, The Lancet.

[18]  W C Dement,et al.  The sleep apnea syndromes. , 1976, Annual review of medicine.

[19]  J. Fleetham,et al.  Mandibular advancement oral appliance therapy for obstructive sleep apnoea: effect on awake calibre of the velopharynx , 1999, Thorax.

[20]  J. Stradling,et al.  A behavioural test to assess daytime sleepiness in obstructive sleep apnoea , 1997, Journal of sleep research.

[21]  S. Ancoli-Israel,et al.  Effect of continuous positive airway pressure vs placebo continuous positive airway pressure on sleep quality in obstructive sleep apnea. , 1999, Chest.

[22]  C. Sullivan,et al.  The immediate effects of nasal continuous positive airway pressure treatment on sleep pattern in patients with obstructive sleep apnea syndrome. , 1986, Electroencephalography and clinical neurophysiology.

[23]  ColinE. Sullivan,et al.  REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.

[24]  D. Stǎnescu,et al.  Increase in ventilatory response to CO2 following tracheostomy in obstructive sleep apnea. , 1980, Bulletin europeen de physiopathologie respiratoire.

[25]  M. Johns,et al.  Daytime sleepiness and sleep habits of Australian workers. , 1997, Sleep.

[26]  W H Rogers,et al.  Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. , 1995, Medical care.

[27]  N. Douglas.  Systematic review of the efficacy of nasal CPAP , 1998, Thorax.

[28]  N J Douglas,et al.  Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? , 1999, American journal of respiratory and critical care medicine.

[29]  J. Pancer,et al.  Evaluation of variable mandibular advancement appliance for treatment of snoring and sleep apnea. , 1999, Chest.

[30]  C. Jenkinson,et al.  Evaluation of treatment for congestive heart failure in patients aged 60 years and older using generic measures of health status (SF-36 and COOP charts). , 1997, Age and ageing.

[31]  T. Sheldon,et al.  Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence , 1997, BMJ.

[32]  D. Fry,et al.  Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy , 1998, Annals of neurology.

[33]  J. Stradling,et al.  Sleep fragmentation indices as predictors of daytime sleepiness and nCPAP response in obstructive sleep apnea. , 1998, American journal of respiratory and critical care medicine.

[34]  R. Fitzpatrick,et al.  Self-reported functioning and well-being in patients with Parkinson's disease: comparison of the short-form health survey (SF-36) and the Parkinson's Disease Questionnaire (PDQ-39) , 1995, Age and ageing.